JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk.
Rebecca L OpenshawJaedeok KwonAlison McCollJosef M PenningerJonathan CavanaghJudith A PrattBrian J MorrisPublished in: Journal of neuroinflammation (2019)
The results demonstrate JNK signalling as a mediator of MIA effects on the foetus. Since both elevated CXCL10 and supressed CXCL12 compromise developing GABAergic interneurons, the results support maternal immune challenge contributing to schizophrenia-associated neurodevelopmental abnormalities. The influence of Map2k7 on cytokine/chemokine induction converges the genetic and environmental aspects of schizophrenia, and the overt influence of maternal genotype offers an intriguing new insight into modulation of embryonic neurodevelopment by genetic risk.